In breast cancer cells, AKR1B10 was associated with acetyl-CoA carboxylase alpha (ACCA), the rate-limiting enzyme of de novo long chain fatty acid synthesis, and knockdown of AKR1B10 in cancer cells led to a significant reduction in both ACCA protein levels and fatty acid synthesis [16]. This evidence concerns the gene AKR1B10 and cancer.